Dr. Henry Miller, PRI’s senior fellow, joins the nationally-syndicated Lars Larson Show to talk about the difference in COVID-19 vaccine efficacy or intended result between the Pfizer, Moderna, and Johnson & Johnson vaccines, with the vaccines ranging from 60 to 90 percent. Miller explains that there is more context to the vaccine efficacy explanation, which depends on when they were tested, approved for emergency use, and available testing at the time of the clinical trials.
Miller also talks about the roles of COVID-19 mutant or variant strains like the South African and Brazilian strains.
Dr. Miller’s segment begins at the 48-minute mark.
